Author response: Quinidine-associated skin discoloration in KCNT1-associated pediatric epilepsy
I thank Dr. Millichap for noting this error in our NeuroImage.1 We agree that it was a mistake to refer to ezogabine as a potassium channel blocker, as it is a positive allosteric modulator of KCNQ2-5.2